Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Videos

Dr Diehl Talks NGS, ctDNA Monitoring, and Organoid Screening in Ongoing BTC Trial

 

Adam Diehl, MD, Fred Hutchinson Cancer Research Center, discusses an ongoing clinical trial assessing the ability to obtain NGS, ctDNA monitoring, and organoid drug sensitivity screening in patients with resected localized biliary tract cancer. These data were presented at the 2021 ASCO GI Cancer Symposium.

 

Advertisement

Advertisement

Advertisement

Advertisement